SCHEMBL19923745

SCHEMBL19923745

CCN1C(=O)N(CC)C(c2ccccc2)(c2ccccc2)C1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.46
BACE2 Q9Y5Z0 1/20 0.46
LMNA P02545 3/20 0.42
HTR1A P08908 2/20 0.39
HTR7 P34969 2/20 0.39
HTR6 P50406 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
THRB P10828 1/20 0.39
MPI P34949 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
MCL1 Q07820 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ADRA1B P35368 1/20 0.39
CYP2C19 P33261 3/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14372430 0.87 NPSR1 (0.49) BACE1BACE2HTR1AHTR7HTR6
SCHEMBL19923474 0.81 BACE1 (0.45) BACE1BACE2LMNAHTR1AHTR7
SCHEMBL19923537 0.80 BACE1 (0.44) BACE1BACE2LMNAKDM4EMEN1
SCHEMBL19923716 0.79 BACE1 (0.40) BACE1BACE2LMNAHTR1AHTR7
SCHEMBL19923661 0.78 BACE1 (0.39) BACE1BACE2LMNAHTR1AHTR7
SCHEMBL19923644 0.76 BACE1 (0.38) BACE1BACE2LMNAHTR1AHTR7
SCHEMBL19923614 0.76 BACE1 (0.38) BACE1BACE2LMNAHTR1AHTR7
SCHEMBL11427471 0.76 ADRA1B (0.39) LMNAHTR1AHTR7HTR6POLB
SCHEMBL19923635 0.75 ELANE (0.53) MEN1KMT2ANPSR1CYP2C19ELANE
SCHEMBL10305541 0.73 BACE1 (0.44) BACE1BACE2LMNAKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US claimed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US claimed
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds BRIDGESTONE CORPORATION (JP) 2021-01-26 US disclosed
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS BRIDGESTONE CORPORATION (JP) 2018-03-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180065935-A1 POLYMERS FUNCTIONALIZED WITH N-PROTECTED HYDANTOIN COMPOUNDS PARG, HNMT, PARN BACE1 4315/4885BACE2 4642/4885LMNA 336/4885
US-10899718-B2 Polymers functionalized with N-protected hydantoin compounds HNMT, PARG, PAM BACE1 4432/4885BACE2 4717/4885LMNA 455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.